Skip to main content

Table 6 Determination of DPPH scavenging activity of eugenol derivatives

From: Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study

Compound/sample

IC50 (µg/mL)a

Sr. no

IC50 (µg/mL)a

5a

9.152 ± 0.063

13a

20.66 ± 0.032

5b

8.304 ± 0.073

13b

12.47 ± 0.014

7

9.786 ± 0.012

13c

16.04 ± 0.026

9a

9.514 ± 0.017

13d

14.88 ± 0.018

9b

9.293 ± 0.028

16

27.70 ± 0.023

11

11.21 ± 0.044

17

31.30 ± 0.014

Eugenol

10.29 ± 0.011

l-Ascorbic acid

8.58 ± 0.009

  1. aValue are expressed as mean ± SEM, n = 3
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us